Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Mathematical Biology
|
March 15, 2014
Integrodifference models for persistence in temporally varying river environments
Jon Jacobsen, Yu Jin, Mark A Lewis
Anesthesia and Analgesia
|
September 16, 2011
The addition of lidocaine to bupivacaine does not shorten the duration of spinal anesthesia: a randomized, double-blinded study of patients undergoing knee arthroscopy
Jon Jacobsen, Bent Husum, Henrik von Staffeldt, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
September 11, 2020
Incremental Density-Based Clustering on Multicore Processors
Son T Mai, Jon Jacobsen, Sihem Amer-Yahia, et al.
Plos Pathogens
|
January 26, 2013
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes
John E Tavis, Xiaohong Cheng, Yuan Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2011
Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region
Robert O Hughes, Todd Maddux, D Joseph Rogier, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
November 28, 2002
Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors
Melissa S Harris, Jeffrey H Bock, Gil Choi, et al.
The Journal of Experimental Medicine
|
March 18, 2018
Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals
Chun Wang, Susan Hockerman, E Jon Jacobsen, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
October 17, 2019
Substrate-based kinase activity inference identifies MK2 as driver of colitis
Samantha Dale Strasser, Phaedra C Ghazi, Alina Starchenko, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
February 1, 2024
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
Paul Changelian, Canxin Xu, Steve Mnich, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Evaluation of aminohydantoins as a novel class of antimalarial agents
Marvin J Meyers, Micky D Tortorella, Jing Xu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Mathematical Biology
|
March 15, 2014
Integrodifference models for persistence in temporally varying river environments
Jon Jacobsen, Yu Jin, Mark A Lewis
Anesthesia and Analgesia
|
September 16, 2011
The addition of lidocaine to bupivacaine does not shorten the duration of spinal anesthesia: a randomized, double-blinded study of patients undergoing knee arthroscopy
Jon Jacobsen, Bent Husum, Henrik von Staffeldt, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence
|
September 11, 2020
Incremental Density-Based Clustering on Multicore Processors
Son T Mai, Jon Jacobsen, Sihem Amer-Yahia, et al.
Plos Pathogens
|
January 26, 2013
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes
John E Tavis, Xiaohong Cheng, Yuan Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2011
Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region
Robert O Hughes, Todd Maddux, D Joseph Rogier, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
November 28, 2002
Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors
Melissa S Harris, Jeffrey H Bock, Gil Choi, et al.
The Journal of Experimental Medicine
|
March 18, 2018
Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals
Chun Wang, Susan Hockerman, E Jon Jacobsen, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
October 17, 2019
Substrate-based kinase activity inference identifies MK2 as driver of colitis
Samantha Dale Strasser, Phaedra C Ghazi, Alina Starchenko, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
February 1, 2024
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
Paul Changelian, Canxin Xu, Steve Mnich, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Evaluation of aminohydantoins as a novel class of antimalarial agents
Marvin J Meyers, Micky D Tortorella, Jing Xu, et al.
Page
of 2